These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37212416)

  • 21. [Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].
    Lund T; Gregersen H; Vangsted A; Marker P; Abildgaard N
    Ugeskr Laeger; 2009 Jan; 171(1-2):50-2. PubMed ID: 19128568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The PENTO protocol in medication-related osteonecrosis of the jaw: A single-center phase IIa trial].
    Dumur A; Pages E; Brie J; Laloze J; Usseglio J
    Bull Cancer; 2024 May; 111(5):537-538. PubMed ID: 38609796
    [No Abstract]   [Full Text] [Related]  

  • 23. Concurrent Osteonecrosis of the Jaw and Hip in a Child With Severe Aplastic Anemia Undergoing Transplant.
    Kaya Z; Kirkiz Kayali S; Topuz Türkcan B; Yilmaz M; Boyunağa Ö; Koçak Ü
    J Pediatr Hematol Oncol; 2024 Oct; 46(7):e522-e523. PubMed ID: 39177969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Somay E
    Osteoporos Int; 2023 Oct; 34(10):1811-1812. PubMed ID: 37418153
    [No Abstract]   [Full Text] [Related]  

  • 26. Bisphosphonate-related osteonecrosis of the jaws of dental origin.
    Pichardo SE; Richard van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):393. PubMed ID: 24440138
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points.
    Rossi M; Gambino A; Cabras M; Alessio M; Fusco V
    Support Care Cancer; 2021 Aug; 29(8):4185-4186. PubMed ID: 33634351
    [No Abstract]   [Full Text] [Related]  

  • 28. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
    Chang JI; Hazboun RC; Chang TI
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
    [No Abstract]   [Full Text] [Related]  

  • 29. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bisphosphonate-related osteonecrosis of the jaws].
    Sogacheva VV; Syomkin VA
    Stomatologiia (Mosk); 2022; 101(6):85-90. PubMed ID: 36562373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Osteonecrosis of the jaw associated with oral treatment with ibandronate].
    Ribas-Deix O; Sanz-Gallén P; Nogué S
    An Sist Sanit Navar; 2011; 34(3):489-91. PubMed ID: 22233853
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

  • 34. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Maahs MP; Azambuja AA; Campos MM; Salum FG; Cherubini K
    Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 36. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 37. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
    Schwartz HC
    J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041
    [No Abstract]   [Full Text] [Related]  

  • 38. Bisphosphonate-related osteonecrosis of the jaws is caused by dental procedures that violate oral epithelium; this is no longer a mysterious disease.
    Jones AC; Sedghizadeh PP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):392-3. PubMed ID: 24252416
    [No Abstract]   [Full Text] [Related]  

  • 39. Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction.
    Tagliamento M; Boutros C; Viansone A; Brau JJ; Descols P
    Eur J Cancer; 2022 May; 166():33-37. PubMed ID: 35272085
    [No Abstract]   [Full Text] [Related]  

  • 40. Plain film and CBCT findings in a case of bisphosphonate-related osteonecrosis of the jaw.
    Singer SR; Mupparapu M
    Quintessence Int; 2009 Feb; 40(2):163-5. PubMed ID: 19169448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.